NOXAFIL
posaconazole
- Strength
- 40 mg/mL
- Form
- Suspension
- Class
- Azole Antifungal
Merck Sharp & Dohme LLC
Posaconazole
Listed by i3 Pharmaceuticals, LLC
- Strength
- 100 mg/1
- Form
- Tablet, Delayed Release
- Route
- Oral
- Class
- Azole Antifungal
What it contains
- Posaconazole 100 mg/1
FDA record
| Dosage form | Tablet, Delayed Release |
|---|---|
| Route | Oral |
| Drug class | Azole Antifungal |
| Approval route | ANDA — approved generic |
| NDC code | 72319-023 |
| FDA application | ANDA216488 |
| RxNorm concept | 1482908 |
| Package sizes listed | 1 |
| Marketed since | September 2023 |
Other products containing Posaconazole
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
NOXAFIL
posaconazole
- Strength
- 100 mg/1
- Form
- Tablet, Coated
- Class
- Azole Antifungal
Merck Sharp & Dohme LLC
NOXAFIL
posaconazole
- Strength
- 300 mg/1
- Form
- Powder, For Suspension
- Class
- Azole Antifungal
Merck Sharp & Dohme LLC
NOXAFIL
posaconazole
- Strength
- 18 mg/mL
- Form
- Solution
- Class
- Azole Antifungal
Merck Sharp & Dohme LLC
POSACONAZOLE
- Strength
- 100 mg/1
- Form
- Tablet, Delayed Release
- Class
- Azole Antifungal
ATLANTIC BIOLOGICALS CORP.
POSACONAZOLE
- Strength
- 100 mg/1
- Form
- Tablet, Coated
- Class
- Azole Antifungal
ENDO USA, Inc.
posaconazole
- Strength
- 18 mg/mL
- Form
- Injection, Solution
- Class
- Azole Antifungal
GLENMARK PHARMACEUTICALS INC., USA
POSACONAZOLE
- Strength
- 100 mg/1
- Form
- Tablet, Delayed Release
- Class
- Azole Antifungal
SpecGx LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.